Next Article in Journal
Atezolizumab/Bevacizumab vs. Lenvatinib as First-Line Therapy for Unresectable Hepatocellular Carcinoma: A Real-World, Multi-Center Study
Next Article in Special Issue
Reducing Immunosuppression in Patients with De Novo Lung Carcinoma after Liver Transplantation Could Significantly Prolong Survival
Previous Article in Journal
Extranodal Marginal Zone Lymphoma: Pathogenesis, Diagnosis and Treatment
Previous Article in Special Issue
How to Improve SBRT Outcomes in NSCLC: From Pre-Clinical Modeling to Successful Clinical Translation
 
 
Article

Article Versions Notes

Cancers 2022, 14(7), 1745; https://doi.org/10.3390/cancers14071745
Action Date Notes Link
article xml file uploaded 29 March 2022 15:38 CEST Original file -
article xml uploaded. 29 March 2022 15:38 CEST Update -
article pdf uploaded. 29 March 2022 15:38 CEST Version of Record https://www.mdpi.com/2072-6694/14/7/1745/pdf-vor
article html file updated 29 March 2022 15:40 CEST Original file -
article xml file uploaded 30 March 2022 06:15 CEST Update -
article xml uploaded. 30 March 2022 06:15 CEST Update https://www.mdpi.com/2072-6694/14/7/1745/xml
article pdf uploaded. 30 March 2022 06:15 CEST Updated version of record https://www.mdpi.com/2072-6694/14/7/1745/pdf
article html file updated 30 March 2022 06:16 CEST Update -
article html file updated 2 August 2022 16:19 CEST Update https://www.mdpi.com/2072-6694/14/7/1745/html
Back to TopTop